Recombinant Influenza A Virus H3N2 Hemagglutinin H3

• Cat.No.: HA H3-201I
• Product Overview: Recombinant Full-Length Influenza A Virus H3N2 Hemagglutinin H3 produced using baculovirus vectors in insect cells, 70 kDa.

Specification

• Cat. No.: HA H3-201I
• Description: Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes.
• Source: Baculovirus infected insect cells
• Purity: > 90% by SDS-PAGE
• Formulation: Liquid
• Concentration: 0.118mg/ml
• Applications: WB: Use a concentration of 0.1 - 1 µg/ml;ELISA: Use at an assay dependent concentration.
• Storage buffer: Preservative: None. Constituents: 500mM Sodium chloride, 30mM Sodium phosphate, pH 7.4
• Storage: Store at +4oC.
• Introduction: Influenza hemagglutinin (HA) is a type of hemagglutinin found on the surface of the influenza viruses. It is an antigenic glycoprotein. It is responsible for binding the virus to the cell that is being infected. HA proteins bind to cells with sialic acid on the membranes, such as cells in the upper respiratory tract or erythrocytes.
• Keywords: Hemagglutinin H3; Hemagglutinin H3 protein; HA H3